INTERNATIONAL EXPERTS IN
RARE CANCERS
Expertise develops through volume, and volume in rare cancers is only achieved at centres serving large catchment areas. Chinese academic centres have built genuine, verifiable subspecialty expertise โ accessible remotely and in person.
What Makes a Centre a Rare Cancer Expert
Genuine rare cancer expertise is specific and verifiable: high annual case volume for the tumour type, published case series in peer-reviewed journals, multidisciplinary rare tumour boards, molecular tumour board capability, subspecialty surgical expertise, and clinical trial portfolio in the specific rare cancer category.
Chinese Academic Centres for Rare Cancers
Each centre has specific rare cancer strengths.
| Centre | Location | Key Rare Cancer Expertise |
|---|---|---|
| Cancer Hospital CAMS | Beijing | Broadest rare cancer programme; sarcoma, ACC, rare gynaecologic tumours; cellular immunotherapy; highest trial volume for rare cancers in China |
| FUSCC | Shanghai | Highest-volume cancer centre; sarcoma, GIST, biliary tract cancer, NET; molecular tumour board; international logistics advantages |
| SPHIC | Shanghai | JCI-accredited; proton/carbon ion for skull base chordoma, chondrosarcoma, spinal sarcomas, paediatric rare tumours |
| PKUPH | Beijing | Haematological rare cancers; haploidentical transplant; rare leukaemia subtypes; NK/T cell lymphoma; aplastic anaemia |
| SYSUCC | Guangzhou | World reference for nasopharyngeal carcinoma; head and neck rare tumours; Southeast Asian patient accessibility |
| 920th Hospital | Kunming | NK cell therapy, CAR NK, DC vaccines; GD2-directed cellular immunotherapy; Southeast Asian accessibility |
Accessing Rare Cancer Experts Remotely
Remote consultation eliminates travel commitment before knowing whether specialist input changes the treatment plan.
Remote Molecular Tumour Board Review
CGP results reviewed by specialist teams at CAMS or FUSCC with treatment recommendations.
Virtual Tumour Board Presentation
Case presented to Chinese specialist team; written clinical opinion and treatment recommendation issued.
Remote Pathology Slide Review
Specialist rare tumour pathologist reviews slides with molecular testing recommendations.
In-Person Coordination
If clinical recommendation requires it, subsequent in-person visit coordinated.
Benefits and Limitations
Benefits
- Genuine, verifiable expertise through published case series and trial data
- Cost substantially lower than Western rare cancer expert centres
- Remote consultation eliminates need for speculative travel
- Geographically accessible for South, Southeast, and East Asian patients
Limitations
- Chinese expertise depth varies by tumour type โ strongest for HCC, gastric, sarcoma, biliary
- Mesothelioma, ACC, and some rare brain tumours have less relative depth
- Expertise concentrated at Tier 1 academic centres only
How to Verify Genuine Expertise
Check PubMed Publications
Search for publications from the institution on the specific rare cancer type. Publications confirm clinical experience.
Ask CancerFax for Volume Data
Request annual case volume and the name of the specialist leading the programme.
Search Clinical Trial Registries
Search ChiCTR.org.cn or ClinicalTrials.gov for trials at the institution for the specific rare cancer.
Frequently Asked Questions
About Rare Cancer Expert Access
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Looking for Specialist Rare Cancer Expertise?
CancerFax matches rare cancer patients to the most appropriate Chinese academic centre programme for their tumour type and molecular profile โ remotely or in person.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.